Jessup Wealth Management Inc Sells 10,711 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Jessup Wealth Management Inc decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 90.1% in the fourth quarter, Holdings Channel reports. The firm owned 1,180 shares of the healthcare conglomerate’s stock after selling 10,711 shares during the quarter. Jessup Wealth Management Inc’s holdings in UnitedHealth Group were worth $597,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of UNH. Financial Perspectives Inc grew its position in UnitedHealth Group by 7.2% in the fourth quarter. Financial Perspectives Inc now owns 4,459 shares of the healthcare conglomerate’s stock valued at $2,256,000 after acquiring an additional 300 shares during the period. Alberta Investment Management Corp grew its holdings in shares of UnitedHealth Group by 211.4% in the 4th quarter. Alberta Investment Management Corp now owns 24,915 shares of the healthcare conglomerate’s stock worth $12,604,000 after purchasing an additional 16,915 shares during the last quarter. Summit Place Financial Advisors LLC lifted its holdings in UnitedHealth Group by 5.1% during the 4th quarter. Summit Place Financial Advisors LLC now owns 5,162 shares of the healthcare conglomerate’s stock valued at $2,611,000 after purchasing an additional 249 shares during the last quarter. Vista Capital Partners Inc. grew its stake in UnitedHealth Group by 19.3% during the fourth quarter. Vista Capital Partners Inc. now owns 737 shares of the healthcare conglomerate’s stock worth $373,000 after buying an additional 119 shares during the last quarter. Finally, Hudson Value Partners LLC raised its stake in shares of UnitedHealth Group by 35.3% in the fourth quarter. Hudson Value Partners LLC now owns 1,446 shares of the healthcare conglomerate’s stock valued at $732,000 after acquiring an additional 377 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 2.0 %

Shares of NYSE UNH opened at $510.75 on Thursday. The stock has a market cap of $470.03 billion, a price-to-earnings ratio of 32.95, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s fifty day moving average is $520.62 and its 200-day moving average is $561.67.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on UNH. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.